Various natural products are reported to improve maternal milk supply yet are not necessarily safe for infants. Researchers have not systematically studied galactagogue teas for safety.
Research aim:
This study evaluates the safety of a galactagogue tea in breastfeeding women and their infants, assessing short- and long-term adverse effects.
Methods:
Healthy, exclusively/fully breastfeeding women (N = 60) with no milk insufficiency were randomized into (1) an all-natural tea containing fruits of bitter fennel, anise, and coriander; fenugreek seed; and other herbs (Mother’s Milk® herbal tea; test) group or (2) a lemon verbena leaf (placebo) group. Maternal diaries captured self-reported maternal and infant adverse effects, tea consumed, and perceived infant satisfaction. Maternal quality of life and psychological state were assessed at baseline and 2 and 4 weeks. Poststudy calls assessed adverse effects through the infants’ age of 12 months.
Results:
No adverse effects attributable to the interventions were reported at any time point. No differences were found between test and placebo groups in sociodemographic characteristics, maternal or infant adverse symptoms, quality of life, breastfeeding self-efficacy, maternal psychological measures, infant growth, and infant satisfaction (all p >.05).
Conclusions:
This double-blind, randomized controlled trial (RCT) of an herbal galactagogue versus placebo among healthy, exclusively/fully breastfeeding mothers and infants found no adverse events associated with the test tea across the 30-day study or the first year of their infant’s life. This composite tea appears to present no safety risk for mothers or their young babies.
The Academy of Breastfeeding Medicine Protocol Committee. (2011). ABM clinical protocol #9: Use of galactogogues in initiating or augmenting the rate of maternal milk secretion. Breastfeeding Medicine, 6(1), 41–49.
2.
AleandriV.BertazzoniG.RomanziD.VetranoG.DurazziF.MazzantiG.VitaloneA. (2014). The use of herbal products during breastfeeding: A study from a public Italian hospital. Journal of Food Processing & Technology, 5(8), 354–360.
American Academy of Pediatrics. (2012). Breastfeeding and the use of human milk. Pediatrics, 129(3), e827–e841.
5.
AnsteyE. H.ChenJ.Elam-EvansL. D. (2017). Racial and geographic differences in breastfeeding: United States, 2011-2015. Morbidity and Mortality Weekly Report, 66, 723–727. http://dx.doi.org/10.15585/mmwr.mm6627a3.
6.
BazzanoA. N.HoferR.ThibeauS.GillispieV.JacobsM.TheallK. P. (2016). A review of herbal and pharmaceutical galactagogues for breast-feeding. The Ochsner Journal, 16(4), 511–524.
7.
BelfortM. B.GillmanM. W. (2013). Healthy infant growth: What are the trade-offs in the developed world?Nestle Nutrition Institute Workshop Series, 71, 171–184.
8.
BonomiA. E.PatrickD. L.BushnellD. M.MartinM. (2000). Validation of the United States’ version of the World Health Organization quality of life (WHOQOL) instrument. Journal of Clinical Epidemiology, 53(1), 1–12.
9.
BrownC. R.DoddsL.LeggeA.BryantonJ.SemenicS. (2014). Factors influencing the reasons why mothers stop breastfeeding. Canadian Journal of Public Health, 105(3), e179–e185.
10.
BudzynskaK.GardnerZ. E.DugouaJ. J.Low DogT.GardinerP. (2012). Systematic review of breastfeeding and herbs. Breastfeeding Medicine, 7(6), 489–503.
11.
Bundesvereinigung Deutscher Apothekerverbände. (2015). Deutscher arzneimittel-codex [German drug codex]. Eschborn, Germany: Govi Verlag.
Commission Nationale de la Pharmacopée Française. (2012). Pharmacopée Française [French Pharmacopeia] (10th ed.). Saint-Denis, France: Agence Française de Sécurité Sanitaire des Produits de Santé–Direction des Laboratoires et des Contrôles.
14.
Council of Europe. (2014). European pharmacopoeia, Edition 8.0. Strasbourg, France: Council of Europe.
15.
CoxJ. L.HoldenJ. M.SagovskyR. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. The British Journal of Psychiatry, 150, 782–786.
16.
DennisC. (2003). The breastfeeding self-efficacy scale: Psychometric assessment of the short form. Journal of Obstetrics and Gynecology Neonatal Nursing, 32(6), 734–744.
17.
DienerE.EmmonsR.LarsenR.GriffinS. (1985). The satisfaction with life scale. Journal of Personality Assessment, 49(1), 71–75.
18.
EidelmanA. I. (2016). The science of herbal galactogogues. Breastfeeding Medicine, 11(7), 331.
19.
GagnierJ. J.BoonH.RochonP.MoherD.BarnesJ.BombardierC., & the CONSORT Group. (2006). Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. Journal of Clinical Epidemiology, 59, 1134–1149.
GökçeoğluE.KüçükoğluS. (2017) The relationship between insufficient milk perception and breastfeeding self-efficacy among Turkish mothers. Global Health Promotion, 24(4), 53–61.
22.
HarrisP. A.TaylorR.ThielkeR.PayneJ.GonzalezN.CondeJ. G. (2009). Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.
23.
HawthorneG.HerrmanH.MurphyB. (2006). Interpreting the WHOQOL-Brèf: Preliminary population norms and effect sizes. Social Indicators Research, 77(7), 37–59.
24.
HoldenS. C.GardinerP.BirdeeG.DavisR. B.YehG. Y. (2015). Complementary and alternative medicine use among women during pregnancy and childbearing years. Birth, 42(3), 261–269.
25.
LabbokM. H.BelseyM.CoffinC. F. (1997). A call for consistency in defining breast-feeding. American Journal of Public Health, 87(6), 1060.
26.
MattheyS.HenshawC.ElliottS.BarnettB. (2006). Variability in use of cut-off scores and formats on the Edinburgh Postnatal Depression Scale: Implications for clinical and research practice. Archives of Women’s Mental Health, 9(6), 309–315.
27.
MortelM.MehtaS. D. (2013). Systematic review of the efficacy of herbal galactogogues. Journal of Human Lactation, 29(2), 154–162.
28.
MurrayL.CarothersA. D. (1990). The validation of the Edinburgh post-natal depression scale on a community sample. British Journal of Psychiatry, 157(2), 288–290.
29.
NgA. W. T.Song Ling PoonS. L.HuangM. N.LimJ. Q.BootA.YuW.SuzukiY.… RozenS. G. (2017). Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Science Translational Medicine, 9(412), doi:10.1126/scitranslmed.aan6446e.
30.
ParitakulP.RuagrongmorakotK.LaosooksaythitW.SuksamarnwongM.PuapornpongP. (2016). The effect of ginger on breast milk volume in the early postpartum period: A randomized, double-bind controlled trial. Breastfeeding Medicine, 11(7), 361–365.
31.
PavotW.DienerE. (1993). Review of the satisfaction with life scale. Psychological Assessment, 5(2), 164–172.
32.
PavotW.DienerE.ColvinC.SandvikE. (1991). Further validation of the satisfaction with life scale: Evidence for the cross-method convergence of well-being measures. Journal of Personality Assessment, 57(1), 149–161.
33.
ShevlinM.BrunsdenV.MilesJ. (1998). Satisfaction with life scale: Analysis of factorial invariance, mean structures and reliability. Personality and Individual Differences, 25, 911–916.
34.
SimT. F.HattinghH. L.SherriffJ.TeeL. B. G. (2014). Perspectives and attitudes of breastfeeding women using herbal galactagogues during breastfeeding: A qualitative study. BMC Complementary and Alternative Medicine, 14, 216–227.
35.
SimT. F.SherriffJ.HattinghH. L.ParsonsR.TeeL. B. G. (2013). The use of herbal medicines during breastfeeding: A population-based survey in Western Australia. BMC Complementary and Alternative Medicine, 13, 317–327.
36.
SkevingtonS.LotfyM.O’ConnellK. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial, a report from the WHOQOL Group. Quality of Life Research, 13, 299–310.
37.
SpielbergerC.GorsuchR.LusheneR. (1970). Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press.
38.
TurkyılmazC.OnalE.HirfanogluI.TuranO.KocE.ErgenekonE. A. Y. (2012). The effect of galactogogue herbal tea on breast milk production and short-term catch-up of birth weight in the first week of life. Journal of Alternative and Complementary Medicine, 17(2), 139–142.
U.S. Food and Drug Administration. (2009). FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs: Agency warns against chronic use of these products to treat gastrointestinal disorders. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149533.htm
41.
WagnerC. L.WagnerM. T.EbelingM.ChatmanK. G.CohenM.HulseyT. C. (2006). The role of personality and other factors in a mother’s decision to initiate breastfeeding. Journal of Human Lactation, 22(1), 16–26.
42.
WebsterJ.NicholasC.VelacottC.CridlandN.FawcettL. (2010). Validation of the WHOQOL-BREF among women following childbirth. Australia and New Zealand Journal of Obstetrics and Gynaecology, 50, 132–137.
World Health Organization Multicentre Growth Reference Study Group. (2006). WHO child growth standards length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva, Switzerland: World Health Organization.
45.
WilkinsonR. B.ScherlF. B. (2006). Psychological health, maternal attachment and attachment style in breast- and formula-feeding mothers: A preliminary study. Journal of Reproductive and Infant Psychology, 24(1), 5–19.
46.
ZuppaA.SindicoP.OrchiC.CarducciC.CardielloV.RomagnoliC. (2012). Safety and efficacy of galactogogues: Substances that induce, maintain and increase breast milk production. Journal of Pharmacology and Pharmaceutical Science, 13(2), 162–174.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
